105 related articles for article (PubMed ID: 6148152)
1. [A 1-year experience with the administration of clopenthixol decanoate in schizophrenic psychoses].
Svestka J; Náhunek K; Cesková E; Rysánek R
Cesk Psychiatr; 1984 Jun; 80(3):146-54. PubMed ID: 6148152
[No Abstract] [Full Text] [Related]
2. A 5-year follow-up study of chronic schizophrenics treated with clopenthixol decanoate.
Carney MW
Pharmatherapeutica; 1984; 4(1):57-63. PubMed ID: 6150493
[TBL] [Abstract][Full Text] [Related]
3. A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients.
Walker CA
Pharmatherapeutica; 1983; 3(5):289-93. PubMed ID: 6133287
[TBL] [Abstract][Full Text] [Related]
4. Long-term treatment of chronic schizophrenics with clopenthixol decanoate.
Borsetti G; Rocco P; Spilimbergo PG; Giavedoni A; Frangiamone L; Beccaceci A; Judice A; Cisternino M; Volterra V
Pharmatherapeutica; 1984; 4(1):53-6. PubMed ID: 6150492
[TBL] [Abstract][Full Text] [Related]
5. [Maintenance therapy using clopenthixol decanoate in schizophrenic patients].
Kabes J; Balon R; Papezová H
Cesk Psychiatr; 1986 Aug; 82(3-4):189-94. PubMed ID: 3769007
[No Abstract] [Full Text] [Related]
6. Clopenthixol decanoate in the treatment of chronic schizophrenic in-patients.
Viswanathan R; Rajhkowa S
Pharmatherapeutica; 1982; 3(2):93-9. PubMed ID: 7100227
[TBL] [Abstract][Full Text] [Related]
7. [cis(Z)-Clopenthixol decanoate--a new depot neuroleptic].
Sieberns S; Spechtmeyer H
Int Pharmacopsychiatry; 1982; 17(3):170-84. PubMed ID: 7141812
[TBL] [Abstract][Full Text] [Related]
8. Clopenthixol decanoate in schizophrenia.
Carney MW; Rutherford P
Curr Med Res Opin; 1981; 7(4):205-11. PubMed ID: 6112116
[TBL] [Abstract][Full Text] [Related]
9. [A new injectable delayed-action neuroleptic with sedative and antipsychotic action: cis-(Z)-clopenthixol decanoate. Clinical trials].
Lambert PA; Chabannes JP
Encephale; 1984; 10(2):83-91. PubMed ID: 6381033
[TBL] [Abstract][Full Text] [Related]
10. Maintenance treatment of chronic schizophrenic patients. A study with the long-acting thioxanthene derivative, cis(Z)-clopenthixol decanoate-sordinol depot.
Dom R; De Mesmaecker L; van den Broucke M; van Hest T; Baro F
Acta Psychiatr Scand; 1978 Apr; 57(4):299-304. PubMed ID: 352094
[TBL] [Abstract][Full Text] [Related]
11. [Clinical experience with Cis-(Z-)Clopenthixol-Decanoate (Sordinol-Depot) (author's transl)].
Zmorski T; Unterrassner R
Schweiz Rundsch Med Prax; 1979 Nov; 68(48):1605-9. PubMed ID: 538008
[No Abstract] [Full Text] [Related]
12. Zuclopenthixol decanoate in schizophrenia: serum levels and clinical state.
Jørgensen A; Aaes-Jørgensen T; Gravem A; Amthor KF; Dencker SJ; Rosell I; Baastrup PC; Buckhave J; Gram LF
Psychopharmacology (Berl); 1985; 87(3):364-7. PubMed ID: 2867572
[TBL] [Abstract][Full Text] [Related]
13. Open multicentre trial of zuclopenthixol in mania and schizophrenia based on the AMDP scales.
Bobon D; Troisfontaines B; Kempeneers JL; Xhenseval B; Bourdouxhe S; Mirel J; Gilson H; Toussaint C; von Frenckell R; Pedersen V
Acta Psychiatr Belg; 1986; 86(2):152-76. PubMed ID: 2873713
[TBL] [Abstract][Full Text] [Related]
14. Cis(Z)-clopenthixol. The neuroleptically active isomer of clopenthixol. A presentation of five double-blind clinical investigations and other studies with cis(Z)-clopenthixol (Cisordinol, Clopixol).
Gravem A; Elgen K
Acta Psychiatr Scand Suppl; 1981; 294():5-12. PubMed ID: 6122337
[No Abstract] [Full Text] [Related]
15. Cis(Z)-clopenthixol. The neuroleptically active isomer of clopenthixol. A presentation of five double-blind clinical investigations and other studies with cis(Z)-clopenthixol (Cisordinol, Clopixol).
Acta Psychiatr Scand Suppl; 1981; 294():1-77. PubMed ID: 6122336
[No Abstract] [Full Text] [Related]
16. Clopenthixol decanoate and perphenazine enanthate in schizophrenic patients. A double-blind Nordic multicentre trial.
Ahlfors UG; Dencker SJ; Gravem A; Remvig J
Acta Psychiatr Scand Suppl; 1980; 279():77-91. PubMed ID: 6996426
[TBL] [Abstract][Full Text] [Related]
17. Clopenthixol decanoate in the management of aggressive mentally handicapped patients.
Mlele TJ; Wiley YV
Br J Psychiatry; 1986 Sep; 149():373-6. PubMed ID: 3779305
[No Abstract] [Full Text] [Related]
18. An open clinical trial with the long-acting neuroleptic zuclopenthixol decanoate in the maintenance treatment of schizophrenia.
Kazi HA
Pharmatherapeutica; 1986; 4(9):555-60. PubMed ID: 3763650
[TBL] [Abstract][Full Text] [Related]
19. A double-blind clinical investigation of cis(Z)-clopenthixol and clopenthixol in chronic schizophrenic patients.
Heikkilä L; Karsten D; Valli K
Acta Psychiatr Scand Suppl; 1981; 294():25-9. PubMed ID: 7041516
[TBL] [Abstract][Full Text] [Related]
20. Zuclopenthixol decanoate in the management of behavioural disorders in mentally handicapped patients.
Izmeth MG; Khan SY; Kumarajeewa DI; Shivanathan S; Veall RM; Wiley YV
Pharmatherapeutica; 1988; 5(4):217-27. PubMed ID: 2902642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
